215
Views
12
CrossRef citations to date
0
Altmetric
Articles

Prevalence and patterns of anti‐nuclear antibodies in Korean children with juvenile idiopathic arthritis according to ILAR criteria

, , , , , & show all
Pages 348-351 | Accepted 19 Feb 2008, Published online: 12 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Xiaolin Ma, Le Xin, Juan Sun & Zhewei Liu. (2016) Antinuclear antibody-positive cohort constitutes homogeneous entity in juvenile idiopathic arthritis. Modern Rheumatology 26:1, pages 75-79.
Read now
I-J Chou, C-F Kuo, L-C See, S-H Hsia, K-H Yu, S-F Luo, C-T Wu & J-L Huang. (2011) Antinuclear antibody status and risk of death in children and adolescents. Scandinavian Journal of Rheumatology 40:6, pages 472-477.
Read now

Articles from other publishers (10)

Mounib M. Sabounji, Hilaire Lissimo & Amina Deme. (2023) Childhood-onset rheumatoid arthritis at a tertiary hospital in Senegal, West Africa. Pediatric Rheumatology 21:1.
Crossref
John A. Storwick, Amanda C. Brett, Katherine Buhler, Alex Chin, Heinrike Schmeling, Nicole A. Johnson, Marvin J. Fritzler & May Y. Choi. (2022) Prevalence and titres of antinuclear antibodies in juvenile idiopathic arthritis: A systematic review and meta-analysis. Autoimmunity Reviews 21:6, pages 103086.
Crossref
Sezgin Sahin, Ceyhun Acari, Hafize Emine Sonmez, Fatma Zehra Kilic, Erdal Sag, Hatice Adiguzel Dundar, Amra Adrovic, Selcan Demir, Kenan Barut, Yelda Bilginer, Betul Sozeri, Erbil Unsal, Seza Ozen & Ozgur Kasapcopur. (2021) Frequency of juvenile idiopathic arthritis and associated uveitis in pediatric rheumatology clinics in Turkey: A retrospective study, JUPITER. Pediatric Rheumatology 19:1.
Crossref
Jeong Yun Choi, Jee Eun Chung, Ji Hyun Park, Yoon Sook Cho, Yong Woo Jung & Soo An Choi. (2018) Surveillance of adverse drug events associated with etanercept prescribed for juvenile idiopathic arthritis in a single center up to 9-years: A retrospective observational study. PLOS ONE 13:11, pages e0204573.
Crossref
Hyuck Jin KwonMyung Hoon BangKwang Nam Kim. (2018) New Provisional Classification of Juvenile Idiopathic Arthritis Applying Rheumatoid Factor and Antinuclear Antibody. Journal of Rheumatic Diseases 25:1, pages 34.
Crossref
Ya-Ping Guo, Chun-Guang Wang, Xin Liu, Yi-Qian Huang, De-Li Guo, Xing-Zhuo Jing, Chun-Gang Yuan, Song Yang, Jin-Mei Liu, Meng-Si Han & Hong-Xing Li. (2014) The Prevalence of Antinuclear Antibodies in the General Population of China: A Cross-Sectional Study. Current Therapeutic Research 76, pages 116-119.
Crossref
Chang-Ching Shen, Kuo-Wei Yeh, Liang-Shiou Ou, Tsung-Chieh Yao, Li-Chen Chen & Jing-Long Huang. (2013) Clinical features of children with juvenile idiopathic arthritis using the ILAR classification criteria: A community-based cohort study in Taiwan. Journal of Microbiology, Immunology and Infection 46:4, pages 288-294.
Crossref
Meenakshi Jolly, Serene Francis & Winston Sequeira. 2013. Dubois' Lupus Erythematosus and Related Syndromes. Dubois' Lupus Erythematosus and Related Syndromes 541 554 .
David S Gibson, Ji Qiu, Eliseo A Mendoza, Kristi Barker, Madeleine E Rooney & Joshua LaBaer. (2012) Circulating and synovial antibody profiling of juvenile arthritis patients by nucleic acid programmable protein arrays. Arthritis Research & Therapy 14:2, pages R77.
Crossref
Ki Hwan KimDong Soo Kim. (2010) Juvenile idiopathic arthritis: Diagnosis and differential diagnosis. Korean Journal of Pediatrics 53:11, pages 931.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.